Bo and colleagues demonstrated that inhibiting HMGB-1 suppressed the proliferation of HESCs in 2016 (20), indicating that targeting HMGB-1 might be a strategy for endometriosis therapy. The gene discussed is HMGB1; the disease is endometriosis.